Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert S Coffin

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
BMC Neuroscience|April 29, 2004
ATF3 upregulation in glia during Wallerian degeneration: differential expression in peripheral nerves and CNS white matterDavid Hunt, Kismet Hossain-Ibrahim, Matthew R J Mason, et al.
The Journal of Infectious Diseases|January 29, 2003
Herpes simplex virus infection of dendritic cells: balance among activation, inhibition, and immunityGabriele Pollara, Katharina Speidel, Laila Samady, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2004
Herpes simplex virus type-1-induced activation of myeloid dendritic cells: the roles of virus cell interaction and paracrine type I IFN secretionGabriele Pollara, Meleri Jones, Matthew E Handley, et al.
Archives of Otolaryngology--Head & Neck Surgery|February 17, 2010
Oncolysis using herpes simplex virus type 1 engineered to express cytosine deaminase and a fusogenic glycoprotein for head and neck squamous cell carcinomaDaniel L Price, Shu-Fu Lin, Ziqun Han, et al.
Journal of Virology|April 13, 2007
Herpes simplex virus type 1 induces CD83 degradation in mature dendritic cells with immediate-early kinetics via the cellular proteasomeMirko Kummer, Nadine M Turza, Petra Muhl-Zurbes, et al.
Journal of Virology|March 1, 2003
Deletion of the virion host shutoff protein (vhs) from herpes simplex virus (HSV) relieves the viral block to dendritic cell activation: potential of vhs- HSV vectors for dendritic cell-mediated immunotherapyLaila Samady, Emanuela Costigliola, Luci MacCormac, et al.
The Journal of General Virology|May 26, 2005
Infection of mature dendritic cells with herpes simplex virus type 1 dramatically reduces lymphoid chemokine-mediated migrationAlexander T Prechtel, Nadine M Turza, Dieter J Kobelt, et al.
Journal for Immunotherapy of Cancer|August 11, 2019
Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1Suzanne Thomas, Linta Kuncheria, Victoria Roulstone, et al.
Stroke|November 12, 2005
Bone marrow stromal cells that enhanced fibroblast growth factor-2 secretion by herpes simplex virus vector improve neurological outcome after transient focal cerebral ischemia in ratsNaokado Ikeda, Naosuke Nonoguchi, Ming Zhu Zhao, et al.
Journal of Neuroscience Research|June 6, 2007
Hepatocyte growth factor promotes endogenous repair and functional recovery after spinal cord injuryKazuya Kitamura, Akio Iwanami, Masaya Nakamura, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
BMC Neuroscience|April 29, 2004
ATF3 upregulation in glia during Wallerian degeneration: differential expression in peripheral nerves and CNS white matterDavid Hunt, Kismet Hossain-Ibrahim, Matthew R J Mason, et al.
The Journal of Infectious Diseases|January 29, 2003
Herpes simplex virus infection of dendritic cells: balance among activation, inhibition, and immunityGabriele Pollara, Katharina Speidel, Laila Samady, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2004
Herpes simplex virus type-1-induced activation of myeloid dendritic cells: the roles of virus cell interaction and paracrine type I IFN secretionGabriele Pollara, Meleri Jones, Matthew E Handley, et al.
Archives of Otolaryngology--Head & Neck Surgery|February 17, 2010
Oncolysis using herpes simplex virus type 1 engineered to express cytosine deaminase and a fusogenic glycoprotein for head and neck squamous cell carcinomaDaniel L Price, Shu-Fu Lin, Ziqun Han, et al.
Journal of Virology|April 13, 2007
Herpes simplex virus type 1 induces CD83 degradation in mature dendritic cells with immediate-early kinetics via the cellular proteasomeMirko Kummer, Nadine M Turza, Petra Muhl-Zurbes, et al.
Journal of Virology|March 1, 2003
Deletion of the virion host shutoff protein (vhs) from herpes simplex virus (HSV) relieves the viral block to dendritic cell activation: potential of vhs- HSV vectors for dendritic cell-mediated immunotherapyLaila Samady, Emanuela Costigliola, Luci MacCormac, et al.
The Journal of General Virology|May 26, 2005
Infection of mature dendritic cells with herpes simplex virus type 1 dramatically reduces lymphoid chemokine-mediated migrationAlexander T Prechtel, Nadine M Turza, Dieter J Kobelt, et al.
Journal for Immunotherapy of Cancer|August 11, 2019
Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1Suzanne Thomas, Linta Kuncheria, Victoria Roulstone, et al.
Stroke|November 12, 2005
Bone marrow stromal cells that enhanced fibroblast growth factor-2 secretion by herpes simplex virus vector improve neurological outcome after transient focal cerebral ischemia in ratsNaokado Ikeda, Naosuke Nonoguchi, Ming Zhu Zhao, et al.
Journal of Neuroscience Research|June 6, 2007
Hepatocyte growth factor promotes endogenous repair and functional recovery after spinal cord injuryKazuya Kitamura, Akio Iwanami, Masaya Nakamura, et al.
Pageof 3